These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15255800)

  • 1. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia.
    Sim K; Su A; Fujii S; Yang SY; Chong MY; Ungvari GS; Si T; Chung EK; Tsang HY; Chan YH; Heckers S; Shinfuku N; Tan CH
    Br J Clin Pharmacol; 2004 Aug; 58(2):178-83. PubMed ID: 15255800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study.
    Sim K; Su A; Leong JY; Yip K; Chong MY; Fujii S; Yang S; Ungvari GS; Si T; Chung EK; Tsang HY; Shinfuku N; Kua EH; Tan CH
    Pharmacopsychiatry; 2004 Jul; 37(4):175-9. PubMed ID: 15467975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001-2009).
    Xiang YT; Li Y; Correll CU; Ungvari GS; Chiu HF; Lai KY; Tang QS; Hao W; Si TM; Wang CY; Lee EH; He YL; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Tan CH; Shinfuku N
    Int J Geriatr Psychiatry; 2014 Apr; 29(4):359-66. PubMed ID: 23939789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies.
    Sim K; Su HC; Fujii S; Yang SY; Chong MY; Ungvari G; Si T; He YL; Chung EK; Chan YH; Shinfuku N; Kua EH; Tan CH; Sartorius N
    Br J Clin Pharmacol; 2009 Jan; 67(1):110-7. PubMed ID: 19133060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.
    Chong MY; Tan CH; Fujii S; Yang SY; Ungvari GS; Si T; Chung EK; Sim K; Tsang HY; Shinfuku N
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):61-7. PubMed ID: 14678459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 8. Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009).
    Xiang YT; Dickerson F; Kreyenbuhl J; Ungvari GS; Wang CY; Si TM; Lee EH; He YL; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    J Clin Psychopharmacol; 2012 Dec; 32(6):809-13. PubMed ID: 23131883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot antipsychotic use in schizophrenia: an East Asian perspective.
    Sim K; Su A; Ungvari GS; Fujii S; Yang SY; Chong MY; Si T; Chung EK; Tsang HY; Chan YH; Shinfuku N; Tan CH
    Hum Psychopharmacol; 2004 Mar; 19(2):103-9. PubMed ID: 14994320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic Polypharmacy in Older Adult Asian Patients With Schizophrenia: Research on Asian Psychotropic Prescription Pattern.
    Dong M; Zeng LN; Zhang Q; Yang SY; Chen LY; Sim K; He YL; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK; Ng CH; Ungvari GS; Xiang YT
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):304-311. PubMed ID: 31480982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
    Sneider B; Pristed SG; Correll CU; Nielsen J
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey.
    Dong M; Zeng LN; Zhang Q; Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HFK; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK; Avasthi A; Grover S; Ng CH; Ungvari GS; Xiang YT
    Asian J Psychiatr; 2019 Oct; 45():74-80. PubMed ID: 31520884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study.
    Aly El-Gabry DM; Abdel Aziz K; Okasha T; Azzam H; Okasha A
    J Clin Psychopharmacol; 2018 Feb; 38(1):27-33. PubMed ID: 29210867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014.
    Fontanella CA; Hiance-Steelesmith DL; Guirgis H; Campo JV
    Psychiatr Serv; 2018 Sep; 69(9):1015-1020. PubMed ID: 29962308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001.
    Sim K; Chuan Su H; Fujii S; Yang SY; Chong MY; Si T; Ling He Y; Kee Chung E; Huak Chan Y; Shinfuku N; Hoon Tan C; Ungvari G; Baldessarini RJ
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):117-23. PubMed ID: 18706129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.